Oncoheroes Biosciences and the Super Sam Foundation walking together for the pediatric cancer Blog Post

Oncoheroes Biosciences announces the receipt of funding from Super Sam Foundation, a pediatric cancer nonprofit organization. Oncoheroes is a Boston based biotech with its European headquarters at the Barcelona Science Park. The startup was co-founded in 2017 by Ricardo Garcia, a serial entrepreneur from Barcelona, and the Italian scientist Cesare Spadoni, two parents touched by childhood cancer and determined to change the outlook for these young patients.

 

EQA develops The Conformity Assessment of Good Practice for Risk Management of COVID-19 Blog Post

EQA, an assessment and certification leading company accredited by ENAC (the Spain national accreditation agency) has developed The Conformity Assessment of Good Practice for Risk Management of COVID-19, as a basis for the progressive return to normality, essential for social and economic recovery. This evaluation is available for all types of facilities and services, whether they continue with their activity or prepare to start it.

 

Researchers identify a molecular auto-control system to avoid an excessive brown adipose tissue activity Blog Post

A scientific team found, lead by Professor Francesc Villarroya, from the Faculty of Biology and the Institute of Biomedicine of the University of Barcelona (IBUB) present in PCB, found a new molecular auto-control system of lipidic metabolism, so far unknown, could help prevent the damaging effects derived from an excessive activation of the brown adipose tissue. The study is published in the journal Nature Communications.

 

Baula donates 18,000 cleaning kits to Càritas Girona Blog Post

The startup Baula, based in the Barcelona Science Park, has donated 18,000 kits of ecological cleaning products to Cáritas Diocesana de Girona, which will be distributed as basic necessities to vulnerable families cared for by the entity. The capsule format facilitates transportation and logistics compared to conventional products. The provision of goods to 18,000 families would equate to 72,000 kilograms of conventional cleaning products. In comparison, Baula’s tablets weigh a total of 4,500 kilograms.

 

Avinent collaborates with Althaia and other institutions to produce PPE with 3D printing technology Blog Post

The company Avinent, present in the Barcelona Science Park, is doing a collaborative project with Althaia Foundation, Bages University Foundation (FUB-UManresa), Eurecat, the Universitat Politécnica de Cataluña (UPC) and Manresa City Council to produce Personal Protective Equipment (PPE) with 3D printing technology. This alliance is concreted with the fabrication of face protection screens and door handles to open with the forearm.

 

SOM Biotech announces the in vitro confirmation of three drug candidates for COVID-19 with the Ewha Womans University Blog Post

SOM Biotech, a clinical-stage drug discovery and development company based in the Barcelona Science Park, announces the in vitro validation of three drug candidates as new therapies for the treatment of COVID-19 in collaboration with the Ewha Womans University in South Korea. A patent application has been filed to provide method of use protection for the three compounds worldwide. All three drugs can be repurposed to treat COVID-19 and the company is working on the fastest way to prove them in patients.

 

Baula raises €1.3M to take the leap to the B2C sector Blog Post

Baula, a technology-based company focused on the ecological and sustainable development of innovative products for the cleaning sector, has closed a €1.3M financing round. The startup specializing in eco-friendly cleaning products will be earmarking this new injection of funds to bolster its human capital, increase production capacity, consolidate its position in the B2B sector and roll out the second phase of its business plan: conquering the domestic and international B2C markets. Since it was established in 2015 in the Barcelona Science Park, Baula has raised 1.8 million euros in public and private capital. It currently has trade agreements in 16 countries in Europe, Africa, North America and Oceania.

 

Nostrum Biodiscovery wins the 2019 of Senén Vilaró Prize for best innovative company Blog Post

Nostrum Biodiscovery (NBD), located at the Barcelona Science Park, has won the “2019 Senén Vilaró Prize for best innovative company”, one of the four awards conferred by the Board of Trustees of the University of Barcelona (UB) and the Bosch i Gimpera Foundation (FBG). The ceremony for the awards was held yesterday at the Aula Magna of the Historical Building of the UB.

 

Meteosim and Olfasense join forces against environmental pollution due to odours Blog Post

The Catalan company Meteosim, based at the Barcelona Science Park, has signed an alliance with the German multinationa Olfasense to provide a comprehensive solution in the smart management of bad odours and resulting conflicts. Through this alliance, the two companies integrate their leading technology in the Ortelium platform, which enables the analysis of the environmental impact of past, current and future episodes, and includes advanced complaint management tools, facilitating smart decision-making in real time.

 

Molomics opens an investment round to accelerate an innovative project against Parkinson’s Blog Post

Molomics Biotech, based in the Barcelona Science Park, has just opened a financing round of 400,000 euros through the online investment platform Capital Cell, allowing also small private investors to acquire shares of the company. With this capital increase, the Spanish startup –which has a financial and professional support of the Michael J. Fox Foundation wants to enter the preclinical phase with an innovative treatment to fight involuntary movements (dyskinesias) associated with Parkinson’s.